ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Baylor Recruits Scardino, Osborne, 13 Others; Likely To Gain Its Second NCI SPORE Grants

April 30, 1999

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003

Decision To Screen For Prostate Cancer Should Include Patients, ACS Panel Says

March 21, 1997

UICC Fellowship, Exchange Programs

July 5, 1985

Max Wicha Describes Michigan’s Restructuring Planning For Growth

May 7, 1999